Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic response in chronic hepatitis delta

被引：0
|
作者：
Zoulim, Fabien [1 ]
Asselah, Tarik [2 ]
Chulanov, Vladimir [3 ]
Streinu-Cercel, Adrian [4 ,5 ]
Gherlan, George Sebastian [5 ,6 ]
Bogomolov, Pavel [7 ]
Stepanova, Tatyana [8 ]
Morozov, Viacheslav [9 ]
Sagalova, Olga [10 ]
Mercier, Renee-Claude [11 ]
Ye, Lei [11 ]
Manuilov, Dmitry [11 ]
Lau, Audrey H. [11 ]
Chee, Grace M. [11 ]
Da, Ben L. [11 ]
Bourliere, Marc [12 ]
Wedemeyer, Heiner [13 ]
Lampertico, Pietro [14 ,15 ]
机构：
[1] Hosp Croix Rousse, Lyon, France
[2] Univ Paris, Hop Beaujon, APHP, INSERM, Clichy, France
[3] Sechenov Univ, Moscow, Russia
[4] Matei Bals Natl Inst Infect Dis, Bucharest, Romania
[5] Carol Davila Univ Med & Pharm, Bucharest, Romania
[6] Victor Babes Fdn, Bucharest, Romania
[7] MF Vladimirsky Moscow Reg Res & Clin Inst, Moscow, Russia
[8] LLC Clin Modern Med, Moscow, Russia
[9] LLC Med Co Hepatol, Samara, Russia
[10] South Ural State Med Univ, Chelyabinsk, Russia
[11] Gilead Sci Inc, Foster City, CA USA
[12] Hop St Joseph, Marseille, France
[13] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany
[14] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[15] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-395
引用
收藏
页码：S796 / S796
页数：1
相关论文
共 50 条
  • [1] 48 Weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection
    Hui, CK
    Lai, LSW
    Lam, P
    Zhang, HY
    Fung, TT
    Lai, ST
    Wong, WM
    Lo, CM
    Fan, ST
    Leung, N
    Lau, GKK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1171 - 1178
  • [2] Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?
    Scholtes, Caroline
    Kumar, Rajneesh
    Zoulim, Fabien
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (13) : 2350 - 2352
  • [3] Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon alpha-2a and Ribavirin for Chronic Hepatitis C
    Rathi, Chetan
    Pipaliya, Nirav
    Choksi, Dhaval
    Parikh, Pathik
    Ingle, Meghraj
    Sawant, Prabha
    ACG CASE REPORTS JOURNAL, 2015, 2 (04): : 247 - 249
  • [4] Nanomedicines in the treatment of chronic hepatitis C - focus on pegylated interferon alpha-2a
    Thomas, Thea
    Foster, Graham
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (01): : 19 - 24
  • [5] Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
    Lai, Lawrence
    Hui, Chee-Kin
    Leung, Nancy
    Lau, George K.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 255 - 262
  • [6] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [7] Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response
    D'Anna, Stefano
    Salpini, Romina
    Degasperi, Elisabetta
    Duca, Leonardo
    Anolli, Maria Paola
    Piermatteo, Lorenzo
    Sambarino, Dana
    Borghi, Marta
    Facchetti, Floriana
    Silberstein, Francesca Ceccherini
    Perbellini, Riccardo
    Svicher, Valentina
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1142 - S1142
  • [8] Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B
    Farag, Mina S.
    van Campenhout, Margo J. H.
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    van Vuuren, Anneke J.
    Ferenci, Peter
    Feld, Jordan J.
    Berg, Thomas
    Hansen, Bettina E.
    van Bommel, Florian
    Janssen, Harry L. A.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 202 - 211
  • [9] The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks
    D'Anna, Stefano
    Salpini, Romina
    Degasperi, Elisabetta
    Duca, Leonardo
    Anolli, Maria Paola
    Piermatteo, Lorenzo
    Sambarino, Dana
    Borghi, Marta
    Facchetti, Floriana
    Silberstein, Francesca Ceccherini
    Perbellini, Riccardo
    Lampertico, Pietro
    Svicher, Valentina
    JOURNAL OF HEPATOLOGY, 2024, 80 : S798 - S798
  • [10] Treatment of chronic hepatitis delta with pegylated interferon-α2b
    Erhardt, Andreas
    Gerlich, Wolfram
    Starke, Christine
    Wend, Ulrike
    Donner, Andreas
    Sagir, Abdurrahman
    Heintges, Tobias
    Haeussinger, Dieter
    LIVER INTERNATIONAL, 2006, 26 (07) : 805 - 810
12345